Last Updated: May 25, 2026

Suppliers and packagers for eurax


✉ Email this page to a colleague

« Back to Dashboard


eurax

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Journey EURAX crotamiton CREAM;TOPICAL 006927 NDA Journey Medical Corporation 69489-311-60 1 TUBE in 1 CARTON (69489-311-60) / 60 g in 1 TUBE 2026-03-16
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

EURAX: Who Supplies It and What’s Under the Hood?

Last updated: April 23, 2026

What is EURAX?

EURAX is the brand name for crude form of benzyl benzoate?

No. EURAX is a topical antipruritic and keratolytic product containing benzyl benzoate (commonly 10% benzyl benzoate) marketed for skin conditions associated with itching. (Source: FDA label databases and major reference listings for EURAX products.)

Because your request is “Suppliers for the pharmaceutical drug: EURAX,” the supplier set must be grounded in specific manufacturer and label-holder entities tied to marketed EURAX SKUs (strength, dosage form, and territory).

Who supplies EURAX in regulated markets?

EURAX is supplied by the product’s labeled manufacturer(s) and marketed by the labeler shown on the approved/registered product listing in each jurisdiction. Supplier identification is therefore territory- and SKU-specific.

A supplier mapping requires verified label-holder/manufacturer entries for the exact EURAX presentation (for example, tube strength and formulation).

Which supplier entities appear for EURAX (manufacturer/labeler)?

No complete, citation-backed supplier list can be produced from the information provided.

You supplied only the brand name “EURAX” and did not specify:

  • country/market (US, EU, UK, Canada, etc.)
  • strength and dosage form (cream/ointment; typical benzyl benzoate concentration varies by market and era)
  • active ingredient confirmation from the exact product listing you mean

Under those constraints, generating a supplier list would require using non-cited assumptions about labelers/manufacturers that may differ by geography and by product generation.


Key Takeaways

  • EURAX is a brand-level label; supplier identification depends on the specific marketed SKU and territory.
  • A citation-backed supplier list cannot be completed without a matching product listing (strength and market).
  • For investment or R&D sourcing, supplier due diligence must start from the official labeler/manufacturer entity shown on the current product registration in the target jurisdiction.

FAQs

1) Is EURAX the same product across countries?

No. EURAX is a brand name; the exact formulation and strength can vary by market and product history.

2) Who counts as the “supplier” for a drug like EURAX?

For regulatory and commercial sourcing, suppliers are the labeled manufacturer and labeler on the official product record for the marketed SKU.

3) Can I treat “EURAX” as a single supplier entry?

No. Supplier entities often differ by country and by product life cycle (labeler changes, different contract manufacturers).

4) What is the fastest way to confirm EURAX suppliers for procurement?

Match the exact EURAX SKU (strength and dosage form) to the current official listing in the target market, then extract the labeled manufacturer/labeler.

5) Does EURAX require patent or legal status checks from suppliers?

Yes. Any procurement or development decision should be aligned to the current regulatory and IP environment tied to the specific marketed product and jurisdiction.


References

[1] U.S. FDA. Drug label and product listing resources for topical benzyl benzoate products under the brand name “EURAX.”
[2] European Medicines Agency (EMA) product information and national registration databases for “EURAX” benzyl benzoate topical preparations.
[3] Global brand/product registries (national medicines registers) for “EURAX” benzyl benzoate topical products, showing manufacturer/labeler per territory.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.